304 related articles for article (PubMed ID: 17722516)
1. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.
Yang H; Kao WJ
Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516
[TBL] [Abstract][Full Text] [Related]
2. Developmental toxicity of low generation PAMAM dendrimers in zebrafish.
Heiden TC; Dengler E; Kao WJ; Heideman W; Peterson RE
Toxicol Appl Pharmacol; 2007 Nov; 225(1):70-9. PubMed ID: 17764713
[TBL] [Abstract][Full Text] [Related]
3. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers.
Pandita D; Santos JL; Rodrigues J; Pêgo AP; Granja PL; Tomás H
Biomacromolecules; 2011 Feb; 12(2):472-81. PubMed ID: 21210673
[TBL] [Abstract][Full Text] [Related]
5. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
[TBL] [Abstract][Full Text] [Related]
6. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
7. IL-6 Antibody and RGD Peptide Conjugated Poly(amidoamine) Dendrimer for Targeted Drug Delivery of HeLa Cells.
Mekuria SL; Debele TA; Chou HY; Tsai HC
J Phys Chem B; 2016 Jan; 120(1):123-30. PubMed ID: 26670944
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
9. Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.
Navath RS; Menjoge AR; Wang B; Romero R; Kannan S; Kannan RM
Biomacromolecules; 2010 Jun; 11(6):1544-63. PubMed ID: 20415504
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
Li J; Zhang X; Wang M; Li X; Mu H; Wang A; Liu W; Li Y; Wu Z; Sun K
Int J Pharm; 2016 Mar; 501(1-2):112-23. PubMed ID: 26828670
[TBL] [Abstract][Full Text] [Related]
11. The effects of an RGD-PAMAM dendrimer conjugate in 3D spheroid culture on cell proliferation, expression and aggregation.
Jiang LY; Lv B; Luo Y
Biomaterials; 2013 Apr; 34(11):2665-73. PubMed ID: 23340194
[TBL] [Abstract][Full Text] [Related]
12. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
Thuy le T; Mallick S; Choi JS
Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the fibroblastic behaviour and surface properties of RGD-immobilized PCL membranes.
Karakecili A; Satriano C; Gumusderelioglu M; Marletta G
J Mater Sci Mater Med; 2007 Feb; 18(2):317-9. PubMed ID: 17323164
[TBL] [Abstract][Full Text] [Related]
14. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
[TBL] [Abstract][Full Text] [Related]
15. Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload.
Yang H; Lopina ST; DiPersio LP; Schmidt SP
J Mater Sci Mater Med; 2008 May; 19(5):1991-7. PubMed ID: 17952565
[TBL] [Abstract][Full Text] [Related]
16. Modified Carboxyl-Terminated PAMAM Dendrimers as Great Cytocompatible Nano-Based Drug Delivery System.
Vu MT; Bach LG; Nguyen DC; Ho MN; Nguyen NH; Tran NQ; Nguyen DH; Nguyen CK; Hoang Thi TT
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022905
[TBL] [Abstract][Full Text] [Related]
17. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
Najlah M; D'Emanuele A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
[TBL] [Abstract][Full Text] [Related]
19. Dendrimers and their applications in immunoassays and clinical diagnostics.
Singh P
Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):1-9. PubMed ID: 17688425
[TBL] [Abstract][Full Text] [Related]
20. Aqueous poly(amidoamine) dendrimer G3 and G4 generations with several interior cores at pHs 5 and 7: a molecular dynamics simulation study.
Kavyani S; Amjad-Iranagh S; Modarress H
J Phys Chem B; 2014 Mar; 118(12):3257-66. PubMed ID: 24588382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]